We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FYX icon
3101
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.4B
-8,600
Closed -$787K
G icon
3102
Genpact
G
$6.24B
-140,515
Closed -$4.88M
GDHG icon
3103
Golden Heaven Group Holdings
GDHG
$80.7M
-4
Closed -$48.2K
GEF icon
3104
Greif
GEF
$5B
-20,670
Closed -$1.36M
GEO icon
3105
PUT
The GEO Group
GEO
$4.31B
-77,100
Closed -$835K
GERN icon
3106
Geron
GERN
$977M
-255,019
Closed -$538K
GGG icon
3107
Graco
GGG
$13.1B
-126,332
Closed -$11M
GHRS icon
3108
GH Research
GHRS
$1.94B
-14,481
Closed -$84K
GIB icon
3109
CGI
GIB
$15.5B
-130,487
Closed -$14M
GLMD icon
3110
Galmed Pharmaceuticals
GLMD
$4.48M
-245
Closed -$10.7K
GLW icon
3111
Corning
GLW
$129B
-74,915
Closed -$2.28M
CBIO
3112
Crescent Biopharma
CBIO
$637M
-596
Closed -$141K
GOTU icon
3113
Gaotu Techedu
GOTU
$401M
-107,100
Closed -$388K
GPC icon
3114
Genuine Parts
GPC
$18.5B
-3,229
Closed -$447K
GPK icon
3115
Graphic Packaging
GPK
$3.54B
-45,500
Closed -$1.12M
GPN icon
3116
Global Payments
GPN
$24.7B
-16,100
Closed -$2.04M
GRBK icon
3117
Green Brick Partners
GRBK
$3.09B
-54,423
Closed -$2.83M
VIP
3118
Vulcan Infrastructure and Power
VIP
$33.7M
-28,058
Closed -$188K
GRMN
3119
Garmin
GRMN
$56.9B
-34,900
Closed -$4.49M
GSHD icon
3120
Goosehead Insurance
GSHD
$2.58B
-14,700
Closed -$1.11M
GSK icon
3121
GSK
GSK
$105B
-290,575
Closed -$10.8M
GSUS icon
3122
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.29B
-22,600
Closed -$1.48M
GTEC icon
3123
Greenland Technologies Holding
GTEC
$24.4M
-10,233
Closed -$28.6K
GWRE icon
3124
Guidewire Software
GWRE
$15.8B
-23,600
Closed -$2.57M
HBCP icon
3125
Home Bancorp
HBCP
$549M
-5,265
Closed -$221K

Similar funds

John Overdeck's Q1 2024 Portfolio in Review

As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, John Overdeck opened a new position in Pfizer worth $234M.

  • John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
  • John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • John Overdeck opened 408 new positions and closed 532 in Q1 2024.
  • John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.